Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study in a real-world clinical setting - Evidence review
In a real-world clinical context, the study linked glycemia at one hour above 155 mg/dL to lower insulin sensitivity and impaired beta-cell function, even with apparently normal tolerance. Independent studies confirm, above all, the early signal of pancreatic dysfunction and future risk, but the threshold value requires contextual clinical interpretation.
- Published 13/11/2026
- Updated 13/11/2026
- Article history
ABSTRACT
The analyzed study evaluated whether elevated plasma glycemia at one hour during an oral glucose tolerance test could identify individuals with metabolic alterations already present, even if they were not classified as prediabetic by traditional fasting and two-hour values. The full text or abstract of the publication is not available in the provided material; therefore, quantitative details, sample size, and analysis of the original study are not reported in the available material.
In the narrative of "The Choice to Live in Health or Illness" by Dr. A. Colonnese and R. Panzironi, the publication contributes to the concept that a one-hour glycemia equal to or greater than 155 mg/dL may serve as an early signal of reduced pancreatic beta-cell function and insulin sensitivity. Independent studies confirm that this profile is associated with poorer beta-cell function and, in selected cohorts, a higher probability of subsequent prediabetes or diabetes. However, this threshold alone does not constitute a diagnosis of diabetes, nor does it prove that every individual will develop the disease.
Analyzed study
Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting
DOI: 10.1007/s12020-015-0746-z
PMID: 26419850
PMCID: PMC5319479
The research question was whether blood glucose measured one hour after glucose intake during an OGTT (oral glucose tolerance test) could identify metabolic alterations before they emerged using standard criteria, which are primarily based on fasting blood glucose and blood glucose after two hours.
The hypothesis relevant to the book's section is that a one-hour blood glucose level above 155 mg/dL is not merely a transient value, but may be associated with lower insulin sensitivity and reduced pancreatic beta-cell function. Beta cells are the cells in the pancreas that produce insulin, the hormone that helps glucose enter tissues.
This is precisely the narrative function of the publication in this section: to support the initial segment of the chain suggesting that an excessive glycemic response after a glucose load can make metabolic alterations visible when conventional classification still indicates normal glucose tolerance. The study can document associations between the one-hour value and metabolic indicators; it cannot, on its own, establish that exceeding the threshold causes diabetes or that early identification automatically changes the clinical course.
Materials and methods of the original study
The provided material indicates that the publication is a pilot study conducted in a real-world clinical setting, focusing on the relationship between one-hour plasma glycemia, dysglycemia, beta-cell function, and insulin sensitivity. However, the full text and abstract are not available in the provided material.
The sample size, inclusion and exclusion criteria, collection period, sex and age composition, the complete OGTT protocol, the techniques used, endpoints, comparison groups, and statistical analyses are not reported in the available material. Therefore, it is not possible to attribute numerical values, confidence intervals, P-values, or risk estimates not present in the input to the original study.
Results
From the verified title of the publication and the excerpt from the book, it appears that the authors observed an association between elevated one-hour plasma glucose levels, dysglycemia, impaired beta-cell function, and lower insulin sensitivity. In simple terms, in people with a higher glycemic peak after a glucose load, the pancreas and insulin-responsive tissues appear to function less effectively.
The available material does not report the magnitude of the observed differences, group means, P-values, odds ratios, or other quantitative results from the original study. Therefore, it is not possible to determine from the provided material alone whether the associations were adjusted for age, sex, body mass index, or other factors that can influence both glycemia and metabolic risk.
The relevant finding for the book's paragraph remains qualitative: a one-hour blood glucose level above 155 mg/dL was used as an indicator associated with a less favorable metabolic profile, even in individuals who did not necessarily appear abnormal according to the conventional OGTT classification.
Interpretation
An early and marked increase in glycemia after a glucose load suggests that glucose regulation may be less efficient. To return glucose to lower levels, both a timely insulin response from beta cells and good insulin sensitivity in the muscles, liver, and adipose tissue are required.
In technical terms, the publication subject to the evidence review supports the link between high one-hour glycemia and two components of the pathophysiology of type 2 diabetes: reduced beta-cell function and reduced insulin sensitivity. This link is consistent with the paragraph, but it does not equate to proof that everyone above the threshold will develop diabetes.
The value of 155 mg/dL should therefore be interpreted as a possible marker of risk and early metabolic alteration, not as an independent diagnosis. Its utility depends on the population studied, the test protocol, individual clinical characteristics, and confirmation through other appropriate tests.
Independent supporting evidence
Initial confirmation of the prognostic component comes from the San Antonio Heart Study. In 1,611 individuals without diabetes at baseline, followed for 7-8 years, a one-hour glycemia of at least 155 mg/dL during an OGTT helped identify subjects with normal glucose tolerance but a high future risk of type 2 diabetes. The study was a prospective observational study: it therefore shows that the value anticipated a subsequent outcome, without demonstrating that the glycemic peak was the direct cause [1].
The component related to pancreatic function was also studied in 113 overweight or obese young people without diabetes, aged between 10 and 20 years. Participants with a one-hour glycemia equal to or greater than 155 mg/dL had a lower disposition index: this index integrates insulin secretion and insulin sensitivity and indicates how well the pancreas is able to compensate for insulin demand. The mean value was 295.1 versus 498.6 mg/kg/min in young people below the threshold, with P<0.001. The difference was present regardless of the glucose tolerance category [2]. The sample was small and composed of young people with excess weight, so the result cannot be automatically transferred to the general adult population.
In a cross-sectional Korean cohort, 43 adults with normal glucose tolerance but elevated one-hour glycemia were compared with 149 subjects below the threshold and 52 people with impaired glucose tolerance. Beta-cell function indices adjusted for insulin sensitivity, namely the oral disposition index and ISSI-2, were lower in the group with elevated one-hour glycemia and similar to those of the group with impaired glucose tolerance [3]. This confirms the passage in the book regarding already compromised beta-cell function, but the cross-sectional design does not allow for measuring individual future risk.
Further longitudinal evidence was collected in 233 obese Latin American youths with a family history of type 2 diabetes. After an annual follow-up of up to eight years, the group with a one-hour glycemia of at least 155 mg/dL showed a greater reduction in beta-cell function over time. Among those who had normal glucose tolerance at baseline, the value above the threshold was associated with a 2.5 times greater probability of developing prediabetes; 95% confidence interval 1.6-4.1, P=0.0001 [4]. The data reinforces the idea of an early signal, but it concerns a high-risk pediatric population and does not prove the efficacy of an intervention based solely on the one-hour value.
Conflicting evidence
No directly conflicting evidence of sufficient relevance has been identified; this does not prove the absence of contrary results.
However, there is a significant difference in the mechanistic component. The Korean study found that insulin sensitivity was substantially comparable between subjects with normal tolerance and high one-hour glycemia and those below the threshold, while beta-cell function was worse in the former group [3]. This picture does not fully align with the narrative of a simultaneous and uniform reduction in insulin sensitivity. The discrepancy suggests that, in some populations and early stages, the defect in insulin secretion may be more evident than insulin resistance.
Consequently, the most consistently confirmed signal is the association between elevated one-hour glycemia and reduced compensatory capacity of beta cells. The relative magnitude of the contribution of insulin resistance may instead vary based on age, population origin, adiposity, family risk, and the method used to estimate insulin sensitivity.
Summary table of evidence
The table distinguishes the publication subject to the Evidence Review from independent research that confirms specific steps of the book's narrative.
| Reference | Study type | Population or model | Main result | Direction of evidence | Strength of evidence |
|---|---|---|---|---|---|
| Original study | Pilot study in a real-world clinical setting | Not reported in available material | Association between elevated one-hour glycemia, dysglycemia, lower insulin sensitivity, and impaired beta-cell function | biologically consistent evidence | preliminary |
| [1] | Prospective observational | 1,611 adults without diabetes at baseline, San Antonio Heart Study | One-hour glycemia helped identify normotolerant individuals at high future risk of diabetes after 7-8 years | direct confirmation | moderate |
| [2] | Observational with experimental metabolic assessments | 113 overweight or obese young people without diabetes | One-hour glycemia ≥155 mg/dL associated with lower disposition index and therefore lower beta-cell function relative to insulin sensitivity | direct confirmation | moderate |
| [3] | Cross-sectional observational | 244 Korean adults with normal or impaired glucose tolerance | Lower beta-cell function in normotolerant individuals with elevated one-hour glycemia, similar to that of subjects with impaired tolerance | direct confirmation | moderate |
| [4] | Prospective observational | 233 obese Latin American youth with a family history of diabetes | One-hour glycemia ≥155 mg/dL associated with greater beta-cell deterioration and a 2.5-fold higher probability of prediabetes | direct confirmation | moderate |
Confirmation of the evidence
Claim in the book
In section 3.1.1 of “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi, a one-hour glycemia equal to or greater than 155 mg/dL during an OGTT is described as an early sign of altered metabolism, associated with an increased risk of type 2 diabetes, reduced beta-cell function, and, subsequently, the contribution of insulin resistance.
Glycemia at one hour ≥155 mg/dL → reduced compensatory capacity of beta cells → early impairment of glucose regulation → higher probability of prediabetes or future diabetes
The publication subject to the Evidence Review was used in the book to support the following passage: individuals with apparently normal glucose tolerance but a one-hour glycemia higher than 155 mg/dL may already show reduced insulin sensitivity and impaired beta-cell function, characteristics that indicate early metabolic alteration.
The connection to “The Choice to Live in Health or Illness” by Dr. A. Colonnese and R. Panzironi is scientifically recognizable: the original study is relevant because it focuses on the one-hour glycemia value as a possible early window into the alterations that precede diabetes. Independent literature reinforces two parts of the narrative. On one hand, an adult cohort followed over time shows that the one-hour value helps identify normotolerant subjects with a higher future risk of diabetes [1]. On the other hand, studies in young people and adults with elevated one-hour glycemia document lower beta-cell function compared to subjects below the threshold [2,3]. In high-risk young people, a value above the threshold has also preceded greater beta-cell deterioration and a higher probability of prediabetes [4].
The chain is therefore supported primarily by the steps: elevated one-hour glycemia → reduced beta-cell function → higher probability of subsequent dysglycemia. The step regarding lower insulin sensitivity is plausible and found in part of the literature, but it does not appear uniform: in the Korean study, the beta-cell defect was more evident than the difference in insulin sensitivity [3].
Overall level of confirmation
STRONG CONFIRMATION
The narrative is supported by multiple independent and converging studies, including prospective studies in humans. The confirmation is more robust for the association with reduced beta-cell function and future metabolic risk; it is less uniform regarding a reduction in insulin sensitivity across all populations.
Conclusions
The original publication is consistent with its use in the book's section: elevated glycemia at one hour during an OGTT may signal metabolic alterations that do not necessarily emerge from fasting or two-hour values. Independent evidence quite robustly supports the association with less efficient beta-cell function and a higher probability of future dysglycemia in selected populations.
However, the 155 mg/dL threshold should not be interpreted as an automatic diagnosis of prediabetes or diabetes. Its significance depends on the clinical context and the population being evaluated. The component related to insulin resistance appears moderately supported, but less consistent compared to the impairment of beta-cell function.
Overall assessment
The narrative is fairly well-supported: elevated glycemia at one hour often identifies a profile with reduced beta-cell function and higher future metabolic risk. The link to insulin resistance is moderately supported and context-dependent. The one-hour value is promising as an early marker, not as a standalone diagnosis.
References
[1] One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes
[2] One-hour plasma glucose concentration during the OGTT: what does it tell about b-cell function relative to insulin sensitivity in overweight/obese children?
[3] Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased b-Cell Function Similar to Impaired Glucose Tolerance
[4] One-Hour Glucose During an Oral Glucose Challenge Prospectively Predicts b-Cell Deterioration and Prediabetes in Obese Hispanic Youth
Editorial note
Artificial Intelligence was used solely as a tool to support editorial and documentary work. All content, interpretations, bibliographic citations and conclusions have been verified, reviewed and approved by the author, who assumes full scientific responsibility for them.
The manuscript was also subject to independent peer review prior to publication.
To ensure maximum transparency, the article's complete history — including the dates of submission, review, acceptance and publication, as well as information on the peer review process — is available on the dedicated Article History page.